No connection

Search Results

LFMDP

BEARISH
$23.8 Live
LifeMD, Inc. · NASDAQ
$18.5 52W Range $25.25
Overview AI Snowflake Price Valuation Profitability Growth Health Statements

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 13, 2026
Market cap
N/A
P/E
N/A
ROE
-131.2%
Profit margin
7.4%
Debt/Equity
0.27
Dividend yield
9.32%

AI Analysis

AI-powered fundamental assessment

Confidence
90%
LFMDP exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic Q/Q revenue decline of 88.98%. While the company maintains high gross margins, the negative operating margin and a devastating ROE of -131.16% suggest a failing business model or massive internal inefficiency. The stock is trading at an extreme premium with a Price/Book ratio of 47.98, and the high dividend yield appears to be a 'dividend trap' given the lack of earnings support. Technical trends are overwhelmingly bearish (10/100), signaling a strong downward momentum.

Key Strengths

Very high gross margins (85.72%)
Low debt-to-equity ratio (0.27)
Adequate short-term liquidity (Current Ratio 1.25)
Positive net profit margin (7.40%) despite operating losses
Strong historical 3-year and 5-year price appreciation

Key Risks

Severe revenue contraction (YoY -27.10%, Q/Q -88.98%)
Extreme overvaluation relative to book value (P/B 47.98)
Deeply negative Return on Equity (-131.16%)
Negative operating margins (-2.34%) indicating unsustainable core operations
Strongly bearish technical trend (10/100)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
24
Weak
Value
10
Future
5
Past
50
Health
20
Dividend
35
AI Verdict
High Risk / Value Trap
Key drivers: Collapsing revenue growth, Extreme P/B ratio, Weak Piotroski F-Score, Negative ROE
Confidence
90%
Value
10/100

P/B ratio suggests the stock is trading at nearly 48x its liquidation value.

Positives
No standout positives identified.
Watchpoints
  • Price/Book ratio of 47.98 is unsustainable
  • No P/E or PEG available due to earnings instability
Future
5/100

Revenue trends indicate a rapid decline in market demand or business viability.

Positives
No standout positives identified.
Watchpoints
  • Q/Q revenue growth plummeted by 88.98%
  • YoY revenue growth is negative 27.10%
Past
50/100

Historical gains are being erased by current fundamental deterioration.

Positives
  • Strong 3Y (+124.8%) and 5Y (+66.3%) returns
Watchpoints
  • Recent technical trend is heavily bearish
Health
20/100

Low debt is the only saving grace in an otherwise failing health profile.

Positives
  • Low Debt/Equity (0.27)
Watchpoints
  • Piotroski F-Score of 2/9 indicates weak financial health
  • Negative ROA and ROE
Dividend
35/100

High yield is likely a result of price decline rather than sustainable profit.

Positives
  • High nominal yield of 9.32%
Watchpoints
  • Dividend strength score is low (40/100)
  • Negative operating margins make payouts unsustainable

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$23.8

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for LFMDP and closest competitors.

Updated 2026-04-10
LFM
LifeMD, Inc.
Primary
5Y
+66.3%
3Y
+124.8%
1Y
+18.6%
6M
+5.5%
1M
+6.7%
1W
+3.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
47.98
P/S Ratio
N/A
EV/Revenue
5.73
EV/EBITDA
-165.62
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin 7.4%
Operating Margin -2.34%
Gross Margin 85.72%
ROE -131.16%
ROA -6.54%

Growth

Revenue and earnings growth rates

Revenue Growth -27.1%
Earnings Growth N/A
Q/Q Revenue Growth -88.98%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.27
Low debt
Current Ratio
1.25
Good
Quick Ratio
1.11
Good
Cash/Share
$0.77

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
40.2%
Op. Margin
-87.9%
Net Margin
282.0%
Total Assets
$0.1B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
2.04x
Operating CF
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
80%

Healthcare Sector Comparison

Comparing LFMDP against 291 companies in the Healthcare sector (20 bullish, 99 neutral, 172 bearish)
Return on Equity (ROE)
-131.16%
This Stock
vs
-49.88%
Sector Avg
+163.0% (Excellent)
Profit Margin
7.4%
This Stock
vs
-9.43%
Sector Avg
-178.4% (Weaker)
Debt to Equity
0.27
This Stock
vs
3.74
Sector Avg
-92.7% (Less Debt)
Revenue Growth
-27.1%
This Stock
vs
80.78%
Sector Avg
-133.5% (Slower)
Current Ratio
1.25
This Stock
vs
3.72
Sector Avg
-66.5% (Weaker)

Past News Coverage

Recent headlines mentioning LFMDP from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile